Verified publication
Optimization of the treatment of anxiety disorders with selank
A comparison of phenazepam monotherapy in 30 patients with combined Selank and phenazepam treatment in 40 patients with anxiety-spectrum disorders.
Indexed abstract extractedQuality: ModerateModerate confidence
Study metadata
- Journal
- Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
- Publication year
- 2015
- Study type
- Human observational study
- Species
- Human
- Evidence grade
- Grade B
- Extraction depth
- Indexed abstract extracted
- Study quality
- Moderate
- Confidence
- Moderate confidence
- Sample size
- 70
Structured extraction
- Population
- Human participants; population details require article-level extraction.
- Intervention
- Exposure or intervention details require abstract or full-text extraction before use.
- Comparator
- Not stated or not fully extracted from the indexed abstract.
- Duration
- Not stated or not fully extracted from the indexed abstract.
- Primary endpoint
- Primary outcome or association endpoint not fully extracted.
- Secondary endpoints
- No secondary endpoints extracted.
- Funding source
- Not stated in the indexed abstract.
Findings and extraction notes
- The indexed abstract reports earlier improvement and fewer phenazepam-associated adverse effects in the combined-treatment group.
Limitations
- The design tests add-on treatment and cannot isolate Selank monotherapy effects.
- Randomization and blinding are not described in the indexed abstract.